Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Shares of Danish pharmaceutical company Novo Nordisk (NVO) are down today despite announcing that its weight loss drug, Wegovy, received support from the Europe...
Novo Nordisk A/S Common Stock NVO experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutic...
Novo Nordisk’s popular weight loss drug Wegovy just got backing from the European Union’s medical regulator to expand its use to include reducing the risk of se...
Analyst ratings
65%
of 31 ratingsMore NVO News
Shares of Novo Nordisk and Eli Lilly slid Thursday after San Diego-based Viking Therapeutics announced that it’s advancing an experimental weight loss drug to a...
Novo Nordisk (NVO) announced Thursday that an independent panel of experts at the EU drug regulator, the European Medicines Agency (EMA), endorsed a label updat...
Viking Therapeutics (VKTX) stock rocketed Thursday after the company said it's exploring a monthly dose of its weight-loss drug. The news is a blow to obesity k...
Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weigh...
Weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) were among the notable decliners in the premarket Thursday after Viking Therapeutics (NASDAQ:...
In Wednesday’s pre-market trading, shares of Novo Nordisk A/S NVO are witnessing a fall after the U.K.’s Medicines and Healthcare products Regulatory Agency (MH...
Britain's Drug Regulator Approves Novo Nordisk's Weight Loss Drug Wegovy To Cut Heart Disease Risk In Obese Patients On Tuesday, the U.K.’s Medicines and Healt...
